Zefeng Cai

996 total citations
29 papers, 503 citations indexed

About

Zefeng Cai is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Zefeng Cai has authored 29 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 18 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Surgery. Recurrent topics in Zefeng Cai's work include Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Blood Pressure and Hypertension Studies (13 papers) and Cardiovascular Health and Disease Prevention (8 papers). Zefeng Cai is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Blood Pressure and Hypertension Studies (13 papers) and Cardiovascular Health and Disease Prevention (8 papers). Zefeng Cai collaborates with scholars based in China, Netherlands and Canada. Zefeng Cai's co-authors include Youren Chen, Guanzhi Chen, Weiqiang Wu, Shouling Wu, Zegui Huang, Zekai Chen, Zhiwei Cai, Zhichao Chen, Yulong Lan and Xianxuan Wang and has published in prestigious journals such as Stroke, Scientific Reports and Hypertension.

In The Last Decade

Zefeng Cai

28 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zefeng Cai China	13	248	245	152	133	50	29	503
Weiqiang Wu China	13	223 0.9×	254 1.0×	135 0.9×	124 0.9×	51 1.0×	40	500
Yulong Lan China	12	197 0.8×	177 0.7×	132 0.9×	66 0.5×	23 0.5×	32	378
Ying-Kai Xu China	7	188 0.8×	231 0.9×	95 0.6×	96 0.7×	33 0.7×	14	380
Benjamin Nilsson Wadström Denmark	9	206 0.8×	267 1.1×	81 0.5×	238 1.8×	65 1.3×	21	527
Chunyu Ruan China	7	108 0.4×	388 1.6×	115 0.8×	49 0.4×	54 1.1×	14	546
Amit Sachdeva United States	6	135 0.5×	220 0.9×	48 0.3×	202 1.5×	33 0.7×	16	452
Ricardo César Solís Mexico	5	198 0.8×	121 0.5×	143 0.9×	51 0.4×	28 0.6×	12	389
Xinchun Yang China	7	77 0.3×	325 1.3×	84 0.6×	54 0.4×	40 0.8×	10	460
Yi-Tong Ma China	11	81 0.3×	104 0.4×	74 0.5×	114 0.9×	33 0.7×	33	363
Aharon Erez Israel	13	94 0.4×	313 1.3×	89 0.6×	148 1.1×	19 0.4×	23	493

Countries citing papers authored by Zefeng Cai

Since Specialization

Citations

This map shows the geographic impact of Zefeng Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zefeng Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zefeng Cai more than expected).

Fields of papers citing papers by Zefeng Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zefeng Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zefeng Cai. The network helps show where Zefeng Cai may publish in the future.

Co-authorship network of co-authors of Zefeng Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Zefeng Cai. A scholar is included among the top collaborators of Zefeng Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zefeng Cai. Zefeng Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Xinde, Shuzhi Lin, Zefeng Cai, & Jilin Li. (2025). Association between cardiovascular-kidney-metabolic syndrome and risk of low cognitive function in older adults: Data from the NHANES 2011–2014. Journal of Alzheimer s Disease. 106(4). 1523–1532. 1 indexed citations

Chen, Zekai, Zhenyu Huo, Peng Fu, et al.. (2025). Metabolic Syndrome Evolution and Cardio-Kidney-Metabolic Multimorbidity. JACC Advances. 4(6). 101778–101778.

Chen, Yanjuan, Weiqiang Wu, Zefeng Cai, et al.. (2025). Association between triglyceride-glucose index and the risk of cardiometabolic diseases in metabolically healthy obese individuals: a prospective cohort study. Frontiers in Endocrinology. 16. 1524786–1524786. 1 indexed citations

Wu, Weiqiang, Zegui Huang, Xianxuan Wang, et al.. (2024). Relationship of the trajectory of the triglyceride-glucose index with heart failure: the Kailuan study. Lipids in Health and Disease. 23(1). 257–257. 3 indexed citations

Huang, Zegui, Weiqiang Wu, Peng Fu, et al.. (2024). Association between the atherogenic index of plasma trajectory and risk of heart failure among hypertensive patients: a prospective cohort study. Cardiovascular Diabetology. 23(1). 301–301. 11 indexed citations

Wu, Weiqiang, Guanzhi Chen, Zefeng Cai, et al.. (2023). Temporal relationship between triglyceride-glucose index and blood pressure and their joint cumulative effect on cardiovascular disease risk: a longitudinal cohort study. Cardiovascular Diabetology. 22(1). 332–332. 12 indexed citations

Huang, Zegui, Guanzhi Chen, Zefeng Cai, et al.. (2023). The effect of acute aerobic exercise on arterial stiffness in individuals with different body fat percentages: A cross-sectional study. Frontiers in Cardiovascular Medicine. 9. 1072191–1072191. 3 indexed citations

Wu, Weiqiang, Yanjuan Chen, Guanzhi Chen, et al.. (2023). Accumulated exposure to high non-high-density lipoprotein cholesterol increases the risk of cardiovascular diseases in hypertensive individuals: An 11-year prospective cohort study. Clinical and Experimental Hypertension. 45(1). 2264540–2264540. 6 indexed citations

Wu, Weiqiang, Guanzhi Chen, Yanjuan Chen, et al.. (2023). Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study. Cardiovascular Diabetology. 22(1). 258–258. 24 indexed citations

10.

Wang, Xianxuan, Weiqiang Wu, Zegui Huang, et al.. (2023). Individual and combined contributions of non-high-density lipoprotein cholesterol and brachial-ankle pulse wave velocity to cardiovascular disease risk: Results of a prospective study using the Kailuan cohort. Frontiers in Cardiovascular Medicine. 10. 1105464–1105464. 1 indexed citations

11.

Chen, Guanzhi, Weiqiang Wu, Zegui Huang, et al.. (2023). Relationship between cumulative exposure to triglyceride-glucose index and heart failure: a prospective cohort study. Cardiovascular Diabetology. 22(1). 239–239. 39 indexed citations

12.

Cai, Zhiwei, Xu Yang, Zegui Huang, et al.. (2023). Age-dependent changes in the risk of weight gain in Chinese adults: results from the Kailuan cohort study. Public Health. 218. 139–145. 3 indexed citations

13.

Wang, Xianxuan, Yanjuan Chen, Zegui Huang, et al.. (2022). Visit-to-visit variability in triglyceride-glucose index and diabetes: A 9-year prospective study in the Kailuan Study. Frontiers in Endocrinology. 13. 1054741–1054741. 10 indexed citations

14.

Wang, Xianxuan, Yanfeng Zhou, Zegui Huang, et al.. (2022). Changes in Impaired Fasting Glucose and Borderline High Low-Density Lipoprotein-Cholesterol Status Alter the Risk of Cardiovascular Disease: A 9-Year Prospective Cohort Study. Frontiers in Cardiovascular Medicine. 9. 882984–882984. 1 indexed citations

15.

Fang, Wei, Zegui Huang, Xianxuan Wang, et al.. (2022). Association between age at onset of overweight and risk of hypertension across adulthood. Heart. 108(9). 683–688. 14 indexed citations

16.

Huang, Zegui, Xianxuan Wang, Xiong Ding, et al.. (2022). Association of Age of Metabolic Syndrome Onset With Cardiovascular Diseases: The Kailuan Study. Frontiers in Endocrinology. 13. 857985–857985. 13 indexed citations

17.

Wang, Xianxuan, Zegui Huang, Zefeng Cai, et al.. (2022). Relationship of cumulative exposure to the triglyceride-glucose index with ischemic stroke: a 9-year prospective study in the Kailuan cohort. Cardiovascular Diabetology. 21(1). 66–66. 53 indexed citations

18.

Huang, Zegui, Xiong Ding, Zekai Chen, et al.. (2022). Triglyceride-glucose index trajectory and stroke incidence in patients with hypertension: a prospective cohort study. Cardiovascular Diabetology. 21(1). 141–141. 90 indexed citations

19.

Cai, Zefeng, Weiqiang Wu, Zekai Chen, et al.. (2021). Long-Term Body Mass Index Variability, Weight Change Slope, and Risk of Cardiovascular Outcomes: 7-Year Prospective Study in Chinese Hypertensive Subjects. Obesity Facts. 14(5). 442–449. 5 indexed citations

20.

Chen, Haojia, Youren Chen, Weiqiang Wu, et al.. (2021). Total cholesterol, arterial stiffness, and systolic blood pressure: a mediation analysis. Scientific Reports. 11(1). 1330–1330. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact